A randomized controlled trial of transcutaneous electrical acupoint stimulation in the prevention of postoperative nausea and vomiting in patients undergoing tympanoplasty

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400082649

Enrollment

Unknown

Registered

2024-04-02

Start date

2024-04-02

Completion date

Unknown

Last updated

2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic tympanitis

Interventions

TEAS Group :TEAS

Sham-TEAS Group :Sham-TEAS

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1 Patients undergoing tympanoplasty under general anesthesia 2 18-65 years old 3 ASA grade I-II

Exclusion criteria

Exclusion criteria: 1 Patients who used antiemetic drugs within 24 hours before operation 2 Patients with nausea or vomiting within 24 hours before operation 3 Patients with abnormal liver and kidney function 4 Diabetic patients 5 Patients with peripheral neuropathy 6 Drug abuse patients 7 Patients with cardiovascular disease ( excluding patients with controlled hypertension ) 8 Patients with mental illness

Design outcomes

Primary

Measure	Time frame
PONV;	—

Secondary

Measure	Time frame
Postoperative pain;	—

Countries

China

Contacts

Public ContactJie Ji'e

Eye & ENT Hospital of Fudan University

jiajie@eentanesthesia.com+86 136 4183 9213

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026